Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Transplantation

Early hospital readmissions after kidney transplantation

Nature Reviews Nephrology volume 10, pages 188–189 (2014)Cite this article

Subjects

A new study reports that 30.5% of kidney transplant recipients have an early hospital readmission (EHR; defined as within 30 days of discharge). As EHR is a strong independent risk factor for allograft loss and mortality, efforts should be made to implement and improve systems to minimize risk of EHR in these patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. McAdams-DeMarco, M. A., Grams, M. E., Hall, E. C., Coresh, J. & Segev, D. L. Early hospital readmission after kidney transplantation: patient and center-level associations. Am. J. Transplant. 12, 3283–3288 (2012).

    Article  CAS  PubMed  Google Scholar 

  2. McAdams-DeMarco, M. A. et al. Frailty and early hospital readmission after kidney transplantation. Am. J. Transplant. 13, 2091–2095 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. McAdams-DeMarco, M. A., Grams, M. E., King, E., Desai, N. M. & Segev, D. L. Sequelae of early hospital readmission after kidney transplantation. Am. J. Transplant. 14, 397–403 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. US Department of Health & Human Services. 2011 OPTN/SRTR Annual Data Report. srtr.transplant.hrsa.gov [online], (2011).

  5. Tait, B. D. et al. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation 95, 19–47 (2013).

    Article  CAS  PubMed  Google Scholar 

  6. Zou, S., Dodd, R. Y., Stramer, S. L., Strong, D. M. & Tissue Safety Study Group. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N. Engl. J. Med. 351, 751–759 (2004).

    Article  CAS  PubMed  Google Scholar 

  7. Pavlakis, M. & Hanto, D. W. Clinical pathways in transplantation: a review and examples from Beth Israel Deaconess Medical Center. Clin. Transplant. 26, 382–386 (2012).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The author would like to thank her colleague Dr Douglas Hanto for his leadership in creating and implementing comprehensive transplant clinical pathways at Beth Israel Deaconess Medical Center.

Author information

Authors and Affiliations

  1. Beth Israel Deaconess Medical Center, Transplant Institute, 110 Francis Street, 7th Floor, Boston, 02215, MA, USA

    Martha Pavlakis

Authors
  1. Martha Pavlakis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martha Pavlakis.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pavlakis, M. Early hospital readmissions after kidney transplantation. Nat Rev Nephrol 10, 188–189 (2014). https://doi.org/10.1038/nrneph.2014.32

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2014.32

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing